CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
WaveLight® FS200 femtosecond laserdevice
Likely dose
WaveLight® FS200 femtosecond laser with 120μm flap creationAI-extracted
Key inclusion· 7
  • ✓Appropriate candidate for uncomplicated bilateral LASIK surgery
  • ✓Age 18 or older
  • ✓Refractive error: sphere 0 to -6D with maximum cylinder up to 3.00D
  • ✓Stable refractive error with less than 0.50D change in preceding year
Key exclusion· 4
  • ✕Severe dry eye, recurrent corneal erosion, uncontrolled glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled diabetes, or herpes
  • ✕Pachymetry below 490μm
  • ✕Autoimmune or immunodeficiency diseases
  • ✕History of previous ocular surgery

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05501795
NCT05501795N/ACompleted
CompareCT.gov

The Accuracy of Flap Thickness Versus the Pre-determined Surgical Planning Using WaveLight® FS200

Stephen Wexler·observational·Posted Aug 15, 2022·Updated Jul 12, 2024

In Brief

An observational study evaluating WaveLight® FS200 femtosecond laser for Myopia. Completed, enrolled 58 participants across 1 site.

Detailed Summary

The objective is to evaluate the resultant thickness of the FS200 created LASIK flap compared to plan at the surgical visit.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 15, 2022
Enrollment StartAug 9, 2022
Primary CompletionJan 19, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.9 years ago

Interventions

WaveLight® FS200 femtosecond laserdevice

Flap creation with the WaveLight® FS200 femtosecond laser